European Pharma’s Pricing Pressures Intensify

In this ISSUE

Luxturna: A Vision for Curative Therapy Access

How Resistors of Change Can Help Enhance RIM Transformation Success

US Drug Pricing & Policy Roundup

Top Story

Renewed Pricing Pressures on European Pharma

As well as official EU projections of sharply slowing industry growth and geopolitical concerns, pharma executives face additional hazards as they plot their medium-term strategies, writes Reflector
… /Read more/

Launching Medical Devices in the Japanese Market - How to navigate regulatory and reimbursement approval
Thursday, October 31, 2019 at 11am EDT

Interview

Sir David Haslam: Looking Back at the Highs (and Lows) at NICE

As Professor Sir David Haslam comes to the end of his six-year tenure as Chair of the UK's National Institute for Health and Care Excellence (NICE), he talks to Leela Barham about the highlights, the lowlights, and what's to come
… /Read more/

Managing Global Regulatory Complexity: Clinical Trial Transparency, Reporting and Real-time Data Driven Compliance
On Demand

Learn More

Technology

What Natural Language Processing Can Do for Pharmacos: 3 Real-World Use Cases

Many real-world data sources contain unstructured text, making it difficult to glean actionable insights from the data. Natural language processing technology can alleviate this problem, writes Jane Z. Reed
… /Read more/

Technology

Liberating Patient Data

Aiden Flynn discusses the mining of real-world data pools to transform drug development
… /Read more/

Opinion

Will AI Kill the Pharma Rep?

By the end of 2020, it is predicted that AI will create more jobs than it is taking. Should reps be concerned, asks David Logue
… /Read more/

Audio

Dr. Cedric Francois: Building Business with Compassion

Apellis' CEO and co-founder Dr. Cedric Francois talks about his journey from clinical work to creating biotech startups
… /Click here to listen/

Calendar

/ September 12– 13: 5^th Annual Compliance Congress for Specialty Products /

Cambridge, MA

/ September 18–19: 5^th Edition Drug Pricing Transparency Congress /

Philadelphia, PA

/ September 25–26: 17^th Annual Pharmaceutical IT & Data Congress /

London, UK

/ October 8–9: Life Sciences West Coast Compliance Congress /

San Francisco, CA

/ November 11–12: FT Global Pharmaceutical and Biotechnology Conference /

London, UK

/ November 13–14: 6^th Annual Global Compliance Congress /

London, UK

/ December 11: eyeforpharma Awards 2019 /

Philadelphia, PA

Industry update

// Macrophage Pharma (Windsor, UK) appointed Dr Søren Bregenholt as Chief Executive Officer. // Dr. Jane Osbourn, OBE was appointed Chair of the Board of Mogrify (Cambridge, UK). // Crescendo Biologics (Cambridge, UK) appointed Stewart Kay as Chief Business Officer. // Professor Gil McVean joined Genomics (Oxford, UK) as Chief Information Officer and member of the senior leadership team. // Tissue Regenix (Leeds, UK) appointed Mike Barker as Chief Financial Officer. // NDA Group announced the appointment of Robert Kronqvist as General Manager for NDA's Nordic affiliate head-quartered in Stockholm, Sweden. // Merck KGaA (Darmstadt, Germany) hired Lisa Benincosa as Senior Vice President, Head of Translational Medicine.

update my profile / advertise with us / print subscribe / digital subscribe / visit pharmexec.com